{{Rsnum
|rsid=2077119
|Gene=AHSG
|Chromosome=3
|position=186612673
|Orientation=plus
|GMAF=0.3792
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(G;G)
|geno2=(G;T)
|geno3=(T;T)
|Gene_s=AHSG
}}{{ population diversity
| geno1=(G;G)
| geno2=(G;T)
| geno3=(T;T)
| CEU | 20.0 | 47.7 | 32.3
| HCB | 35.6 | 46.7 | 17.8
| JPT | 27.3 | 50.0 | 22.7
| YRI | 0.0 | 3.2 | 96.8
| ASW | 0.0 | 0.0 | 0.0
| CHB | 35.6 | 46.7 | 17.8
| CHD | 0.0 | 0.0 | 0.0
| GIH | 0.0 | 0.0 | 0.0
| LWK | 0.0 | 0.0 | 0.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 0.0 | 0.0 | 0.0
| TSI | 0.0 | 0.0 | 0.0
| HapMapRevision=28
}}[[rs2077119]], also known as -469T/G, is a SNP in the alpha-2-HS-glycoprotein [[AHSG]] gene.

In a study of ~3,800 Danish [[type-2 diabetes]] patients, pooled with a previous study, the minor [[rs2077119]](G) allele showed a slight protective effect, with an odds ratio of 0.91 (CI: 0.84-0.99, p=0.007).{{PMID|18316360}}

{{PMID Auto
|PMID=17889958
|Title=A promoter polymorphism of the alpha2-HS glycoprotein gene is associated with its transcriptional activity.
}}

{{PMID Auto
|PMID=22024217
|Title=Are AHSG polymorphisms directly associated with coronary atherosclerosis?
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | FTDNA2}}
{{on chip | HumanOmni1Quad}}